PRESS RELEASES

Date	Title
Feb 28, 2022	Ardelyx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
Feb 24, 2022	Ardelyx Announces $27.5 Million Debt Financing Agreement with SLR Capital Partners
Feb 22, 2022	Ardelyx to Report Fourth Quarter and Year-End 2021 Financial Results and Provide Corporate Update on February 28, 2022
Feb 4, 2022	Ardelyx, Inc. Reports Employment Inducement Grants
Nov 30, 2021	Ardelyx Launching IBSRELA® Second Quarter of 2022
Nov 12, 2021	Ardelyx Reports Third Quarter 2021 Financial Results
Nov 11, 2021	Ardelyx to Present at the Jefferies London Healthcare Conference
Nov 5, 2021	Ardelyx Reports Additional Positive Data Supporting Clinical Utility of Tenapanor at ASN's Kidney Week 2021
Nov 4, 2021	Ardelyx to Pursue Formal Dispute Resolution for Tenapanor
Oct 29, 2021	Ardelyx Announces Four Tenapanor Presentations at ASN's Kidney Week 2021

FAQs

Email Alerts

Connect

Bay Area
34175 Ardenwood Boulevard
Fremont, CA 94555

Greater Boston
400 Fifth Avenue, Suite 210
Waltham, MA 02451

Phone: 617.675.ARDX (2739)

Inquiries:
General: info@ardelyx.com
Media: media@ardelyx.com
Investor: investor@ardelyx.com
Business Development: partnering@ardelyx.com